PET Trial to Assess the Receptor Occupancy of Brexpiprazole in Adult Subjects With Schizophrenia
Phase of Trial: Phase I
Latest Information Update: 11 Feb 2016
At a glance
- Drugs Brexpiprazole (Primary)
- Indications Schizophrenia
- Focus Pharmacodynamics
- 31 Aug 2018 Biomarkers information updated
- 15 Apr 2015 Status changed from recruiting to completed as per ClinicalTrials.gov record.
- 20 Sep 2013 Planned number of patients changed from 18 to 12 as reported by ClinicalTrials.gov.